| 000 | 01819 a2200541 4500 | ||
|---|---|---|---|
| 005 | 20250514024408.0 | ||
| 264 | 0 | _c20020304 | |
| 008 | 200203s 0 0 eng d | ||
| 022 | _a1524-4539 | ||
| 024 | 7 |
_a10.1161/hc0802.104280 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFurberg, Curt D | |
| 245 | 0 | 0 |
_aSubgroup interactions in the Heart and Estrogen/Progestin Replacement Study: lessons learned. _h[electronic resource] |
| 260 |
_bCirculation _cFeb 2002 |
||
| 300 |
_a917-22 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aCoronary Disease _xblood |
| 650 | 0 | 4 | _aData Interpretation, Statistical |
| 650 | 0 | 4 | _aDemography |
| 650 | 0 | 4 | _aDigitalis |
| 650 | 0 | 4 | _aDisease Progression |
| 650 | 0 | 4 | _aDrug Interactions |
| 650 | 0 | 4 |
_aEstrogen Replacement Therapy _xstatistics & numerical data |
| 650 | 0 | 4 |
_aEstrogens, Conjugated (USP) _xadministration & dosage |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aLife Style |
| 650 | 0 | 4 |
_aLipoprotein(a) _xblood |
| 650 | 0 | 4 |
_aMedroxyprogesterone Acetate _xadministration & dosage |
| 650 | 0 | 4 | _aParity |
| 650 | 0 | 4 | _aPostmenopause |
| 650 | 0 | 4 | _aProportional Hazards Models |
| 650 | 0 | 4 |
_aRandomized Controlled Trials as Topic _xstatistics & numerical data |
| 650 | 0 | 4 | _aRisk |
| 650 | 0 | 4 | _aSurvival Rate |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aVittinghoff, Eric | |
| 700 | 1 | _aDavidson, Michael | |
| 700 | 1 | _aHerrington, David M | |
| 700 | 1 | _aSimon, Joel A | |
| 700 | 1 | _aWenger, Nanette K | |
| 700 | 1 | _aHulley, Stephen | |
| 773 | 0 |
_tCirculation _gvol. 105 _gno. 8 _gp. 917-22 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1161/hc0802.104280 _zAvailable from publisher's website |
| 999 |
_c11772684 _d11772684 |
||